Literature DB >> 1385327

Increased transcripts for B-type natriuretic peptide in spontaneously hypertensive rats. Quantitative polymerase chain reaction for atrial and brain natriuretic peptide transcripts.

L Dagnino1, J P Lavigne, M Nemer.   

Abstract

The cardiac natriuretic peptide family includes atrial natriuretic factor and brain or B-type natriuretic peptide, also known as iso-atrial natriuretic factor (isoANF). Although these peptides contribute to cardiovascular homeostasis, their respective roles remain unclear. To study regulation of atrial natriuretic factor and isoANF gene expression during progression of hypertension, we developed a quantitative polymerase chain reaction protocol to measure their transcript level in spontaneously hypertensive rat (SHR) hearts. At the onset of hypertension, atrial natriuretic factor transcripts in 5-week-old SHR were 50% of those of age-matched Wistar-Kyoto (WKY) rats, whereas the level of isoANF transcripts was similar in atria and twofold higher in ventricles. Because atria are the major sites of atrial natriuretic factor gene expression and ventricles contribute predominantly to cardiac isoANF synthesis, total atrial natriuretic factor messenger RNA (mRNA) in the hearts of 5-week-old SHR was about 50% of that in WKY rats, and total isoANF mRNA content was already higher than in control rats. In left ventricles and ventricular septa, progression of hypertension led to a maximal increase of twofold and fourfold in atrial natriuretic factor and isoANF mRNA levels, respectively, with no detectable change in right ventricles. In the atria of older SHR, atrial natriuretic factor and isoANF mRNA levels were comparable to those of age-matched controls. These data indicate that, although increased blood pressure stimulates both atrial natriuretic factor and isoANF gene expression, regulation of the two natriuretic peptide genes is not temporally coordinated in all cardiac compartments. Furthermore, isoANF mRNA is already induced in the ventricles at the onset of the hypertensive stage, and in older SHR, the isoANF gene is hyperresponsive to progression of hypertension compared with atrial natriuretic factor. Thus, isoANF might represent a very sensitive marker of cardiac changes in hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385327     DOI: 10.1161/01.hyp.20.5.690

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice.

Authors:  M Y Tse; J D Watson; I R Sarda; T G Flynn; S C Pang
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Effects of exercise training on pathological cardiac hypertrophy related gene expression and apoptosis.

Authors:  Young I Lee; Joon Y Cho; Mun H Kim; Kee B Kim; Dong J Lee; Kyu S Lee
Journal:  Eur J Appl Physiol       Date:  2006-04-01       Impact factor: 3.078

3.  Detection of C-type natriuretic peptide compared with brain and atrial natriuretic peptide transcripts in human heart by the polymerase chain reaction.

Authors:  A L Gerbes; M Nemer
Journal:  Clin Investig       Date:  1993-08

4.  A rapid procedure for the quantitation of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects.

Authors:  M R Iascone; S Vittorini; A Collavoli; A Cupelli; G Kraft; A Biagini; A Clerico
Journal:  J Endocrinol Invest       Date:  1999-12       Impact factor: 4.256

5.  Differential gene expression of the three natriuretic peptides and natriuretic peptide receptor subtypes in human liver.

Authors:  A M Vollmar; G Paumgartner; A L Gerbes
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

6.  A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription.

Authors:  C Grépin; L Dagnino; L Robitaille; L Haberstroh; T Antakly; M Nemer
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  Expression and differential regulation of natriuretic peptides in mouse macrophages.

Authors:  A M Vollmar; R Schulz
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

Authors:  L A Brown; D J Nunez; M R Wilkins
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

9.  Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.

Authors:  Katarzyna Kazmierczak; Chen-Ching Yuan; Jingsheng Liang; Wenrui Huang; Ana I Rojas; Danuta Szczesna-Cordary
Journal:  Front Physiol       Date:  2014-09-22       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.